TRIB
Trinity Biotech plc
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$9.41
−1.98%Margins
Gross margin
35.4%
EBITDA margin
-19.5%
EBIT margin
-25.7%
Net margin
-85.3%
FCF margin
-14.5%
52.0%
Return on equity
-35.6%
Return on assets
-17.1%
Return on invested capital
0.42x
Asset turnover
-$6.3M
Cash from operations
$6.32
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025